glucaric acid has been researched along with Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fei, Y; Li, Y; Liang, B; Shen, W; Yin, Q; Zhao, B; Zhu, J; Zhu, X | 1 |
1 other study(ies) available for glucaric acid and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
JLX001 attenuates blood-brain barrier dysfunction in MCAO/R rats via activating the Wnt/β-catenin signaling pathway.
Topics: Animals; Blood-Brain Barrier; Brain Ischemia; Cell Survival; Cerebral Cortex; Endothelial Cells; Glucaric Acid; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 9; Microvessels; Neuroprotective Agents; Oxygen; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Reperfusion; Triterpenes; Wnt Signaling Pathway | 2020 |